Paxlovid (nirmatrelvir co-packaged with ritonavir)
A Preferred Oral Antiviral Drug to Treat COVID-19
Updates about the medication that are updated regularly.
On May 25, 2023, FDA approved Pfizer’s application for Paxlovid to treat adults.
A Preferred Oral Antiviral Drug to Treat COVID-19
Updates about the medication that are updated regularly.
On May 25, 2023, FDA approved Pfizer’s application for Paxlovid to treat adults.